Visiting any medical facility is nightmare fuel for millions of Americans, and a lurking bacteria threatens to strike the ...

Restarting subcutaneous infliximab 240 mg after treatment interruption of at least 16 weeks was able to recapture response ...

Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced that it has entered into an asset purchase agreement with Matrivax ...

The treatment for ulcerative colitis and Crohn’s disease combines two already available drugs that worked better in clinical ...

A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.

Probiotic supplements might not have any effect on health if they aren't the right strains or if they die before reaching the ...

VIENNA, Austria, March 18, 2026 /PRNewswire/ -- Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive ...

Using the National Inpatient Sample, the largest publicly available all-payer inpatient care database in the US, the research team analyzed data for nearly 4.2 million adults hospitalized with a ...

Background Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis, ...

Gastrointestinal tumors remain a global health challenge, with high incidence and mortality. Among them, colorectal cancer (CRC) carries the heaviest burden and serves as a key model for how the gut ...

Fecal microbiota transplantation (FMT), shown to be effective in the treatment of recurrent Clostridioides difficile infection (CDI), also shows significant benefit in the treatment of primary CDI, ...